trial · primary record
survodutide
Healthy
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2026-07-28 |
| Primary endpoint | Area under the concentration-time curve of the analyte in plasma at steady state over a uniform dosing interval τ (AUCτ,ss) |
| Registry ID | NCT07221591 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:15.615Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07221591
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.